Failure of omalizumab for treatment of severe adult atopic dermatitis

被引：136

作者：

Krathen, RA ^{[1
]}

Hsu, S ^{[1
]}

机构：

[1] Baylor Coll Med, Dept Dermatol, Houston, TX 77030 USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2005年 / 53卷 / 02期

关键词：

D O I：

10.1016/j.jaad.2005.02.014

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Atopic dermatitis has been associated with elevated levels of IgE. Omalizumab is a monoclonal anti-IgE antibody currently approved for the treatment of asthma. We report the failure of omalizumab to improve atopic dermatitis in 3 patients when administered for 4 months.

引用

页码：338 / 340

页数：3

共 20 条

[11] Omalizumab is effective in the long-term control of severe allergic asthma [J].

Lanier, BQ ;

Corren, J ;

Lumry, W ;

Liu, J ;

Fowler-Taylor, A ;

Gupta, N .

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2003, 91 (02) :154-159

[12] Does the severity of atopic dermatitis correlate with serum IgE levels? [J].

Laske, N ;

Niggemann, B .

PEDIATRIC ALLERGY AND IMMUNOLOGY, 2004, 15 (01) :86-88

[13] Effect of omalizumab in health care workers with occupational latex allergy [J].

Leynadier, F ;

Doudou, O ;

Gaouar, H ;

Le Gros, V ;

Bourdeix, I ;

Guyomarch-Cocco, L ;

Trunet, P .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 113 (02) :360-361

[14]

MacGlashan DW, 1997, J IMMUNOL, V158, P1438

[15] Treatment of allergic asthma with monoclonal anti-IgE antibody [J].

Milgrom, H ;

Fick, RB ;

Su, JQ ;

Reimann, JD ;

Bush, RK ;

Watrous, ML ;

Metzger, WJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (26) :1966-1973

[16] Treatment of atopic eczema with oral mycophenolate mofetil [J].

Neuber, K ;

Schwartz, I ;

Itschert, G ;

Dieck, AT .

BRITISH JOURNAL OF DERMATOLOGY, 2000, 143 (02) :385-391

[17] Omalizumab treatment downregulates dendritic cell FcεF-RI expression [J].

Prussin, C ;

Griffith, DT ;

Boesel, KM ;

Lin, H ;

Foster, B ;

Casale, TB .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 112 (06) :1147-1154

[18] The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics [J].

Solèr, M ;

Matz, J ;

Townley, R ;

Buhl, R ;

O'Brien, J ;

Fox, H ;

Thirlwell, J ;

Gupta, N ;

Della Cioppa, G .

EUROPEAN RESPIRATORY JOURNAL, 2001, 18 (02) :254-261

[19] Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR [J].

Vignola, AM ;

Humbert, M ;

Bousquet, J ;

Boulet, LP ;

Hedgecock, S ;

Blogg, M ;

Fox, H ;

Surrey, K .

ALLERGY, 2004, 59 (07) :709-717

[20] Ultraviolet A and melanoma: A review [J].

Wang, SQ ;

Setlow, R ;

Berwick, M ;

Polsky, D ;

Marghoob, AA ;

Kopf, AW ;

Bart, RS .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2001, 44 (05) :837-846

← 1 2 →